These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8973055)

  • 1. Growth hormone response to apomorphine in obsessive-compulsive disorder.
    Pitchot W; Hansenne M; Moreno AG; Ansseau M
    J Psychiatry Neurosci; 1996 Nov; 21(5):343-5. PubMed ID: 8973055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.
    Brambilla F; Bellodi L; Perna G; Arancio C; Bertani A
    Biol Psychiatry; 1997 Nov; 42(10):889-97. PubMed ID: 9359974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder.
    Kluge M; Schüssler P; Weikel J; Dresler M; Zuber V; Querfurt F; Yassouridis A; Steiger A
    Psychoneuroendocrinology; 2006 Oct; 31(9):1098-104. PubMed ID: 16965859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines].
    Pitchot W; Hansenne M; Gonzalez Moreno A; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1995; 95(4-5):210-33. PubMed ID: 8525861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview.
    du Toit PL; van Kradenburg J; Niehaus D; Stein DJ
    Compr Psychiatry; 2001; 42(4):291-300. PubMed ID: 11458303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone response to low-dose apomorphine in restless legs syndrome.
    Happe S; Bachmann CG; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Growth Horm IGF Res; 2007 Aug; 17(4):323-7. PubMed ID: 17512770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth hormone response to baclofen in obsessive compulsive disorder: does the GABA-B receptor mediate obsessive anxiety?
    Lucey JV; Butcher G; O'Flynn K; Clare AW; Dinan G
    Pharmacopsychiatry; 1994 Jan; 27(1):23-6. PubMed ID: 8159779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.
    Koo MS; Kim EJ; Roh D; Kim CH
    Expert Rev Neurother; 2010 Feb; 10(2):275-90. PubMed ID: 20136383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bipolar obsessive-compulsive disorder: confirmation of results of the "ABC-OCD" survey in 2 populations of patient members versus non-members of an association].
    Hantouche EG; Kochman F; Demonfaucon C; Barrot I; Millet B; Lancrenon S; Akiskal HS
    Encephale; 2002; 28(1):21-8. PubMed ID: 11963340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessive-compulsive bipolar comorbidity: focus on children and adolescents.
    Masi G; Perugi G; Toni C; Millepiedi S; Mucci M; Bertini N; Akiskal HS
    J Affect Disord; 2004 Mar; 78(3):175-83. PubMed ID: 15013241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N; Tan LW; Wang Q; Li ZX; Li LJ
    Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin and leptin levels in patients with obsessive-compulsive disorder.
    Emül HM; Serteser M; Kurt E; Ozbulut O; Guler O; Gecici O
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1270-4. PubMed ID: 17597276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder.
    Kluge M; Schüssler P; Künzel HE; Dresler M; Yassouridis A; Steiger A
    J Psychiatr Res; 2007 Dec; 41(11):928-33. PubMed ID: 17049559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar obsessive-compulsive disorder and personality disorders.
    Maina G; Albert U; Pessina E; Bogetto F
    Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum leptin levels in obsessive-compulsive disorder.
    Atmaca M; Tezcan E; Kuloglu M; Ustundag B
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):189-93. PubMed ID: 15823166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive disorder with comorbid major depression: what is the role of cognitive factors?
    Abramowitz JS; Storch EA; Keeley M; Cordell E
    Behav Res Ther; 2007 Oct; 45(10):2257-67. PubMed ID: 17521605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
    Hantouche EG; Bouhassira M; Lancrenon S
    Encephale; 2000; 26(6):73-83. PubMed ID: 11217541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma nitrate values in patients with obsessive-compulsive disorder.
    Atmaca M; Tezcan E; Kuloglu M; Ustundag B
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):621-3. PubMed ID: 16194270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.